Peer ambassadors may boost clinical trial enrollment in gynecologic cancer

NCT ID NCT06711380

Completed Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a peer ambassador program could help more gynecologic cancer patients learn about and join clinical trials. Twenty-three patients with advanced or recurrent gynecologic cancer were paired with a mentor who had personal experience with cancer and clinical trials. The goal was to see if this approach was feasible and acceptable to patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Peer ambassador program (patient mentor with gynecologic cancer history)
What this could lead to: If successful, this program could provide a model to improve clinical trial enrollment among gynecologic cancer patients.
What could go wrong: This is a small, completed feasibility study with only 23 participants, so results may not apply broadly. It measures feasibility and acceptability, not direct health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GYNECOLOGIC CANCER

Contacts and locations

Locations

Perelman Center for Advanced Medicine

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.